P3 Health Partners Net Income
| PIII Stock | USD 2.56 0.41 19.07% |
As of the 10th of February, P3 Health owns the information ratio of (0.22), and Market Risk Adjusted Performance of (1.42). In connection with fundamental indicators, the technical analysis model allows you to check timely technical drivers of P3 Health Partners, as well as the relationship between them.
P3 Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.1622 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -279.3 M | -293.3 M | |
| Net Loss | -279.3 M | -265.4 M | |
| Net Loss | -11.6 M | -12.2 M | |
| Net Loss | (53.80) | (56.49) | |
| Net Income Per E B T | 0.51 | 0.57 |
PIII | Net Income | Build AI portfolio with PIII Stock |
The Net Income trend for P3 Health Partners offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether P3 Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest P3 Health's Net Income Growth Pattern
Below is the plot of the Net Income of P3 Health Partners over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in P3 Health Partners financial statement analysis. It represents the amount of money remaining after all of P3 Health Partners operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is P3 Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in P3 Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (310.38 M) | 10 Years Trend |
|
Net Income |
| Timeline |
PIII Net Income Regression Statistics
| Arithmetic Mean | (85,418,362) | |
| Coefficient Of Variation | (90.27) | |
| Mean Deviation | 58,782,658 | |
| Median | (43,801,295) | |
| Standard Deviation | 77,110,854 | |
| Sample Variance | 5946.1T | |
| Range | 238.7M | |
| R-Value | (0.55) | |
| Mean Square Error | 4447.3T | |
| R-Squared | 0.30 | |
| Significance | 0.02 | |
| Slope | (8,347,214) | |
| Total Sum of Squares | 95137.3T |
PIII Net Income History
Other Fundumenentals of P3 Health Partners
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
P3 Health Net Income component correlations
PIII Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for P3 Health is extremely important. It helps to project a fair market value of PIII Stock properly, considering its historical fundamentals such as Net Income. Since P3 Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of P3 Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of P3 Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will PIII introduce new products? Factors like these will boost the valuation of P3 Health. Anticipated expansion of PIII directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (57.16) | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets | Return On Equity |
P3 Health Partners's market price often diverges from its book value, the accounting figure shown on PIII's balance sheet. Smart investors calculate P3 Health's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since P3 Health's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between P3 Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding P3 Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
P3 Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to P3 Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of P3 Health.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in P3 Health on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding P3 Health Partners or generate 0.0% return on investment in P3 Health over 90 days. P3 Health is related to or competes with Vicarious Surgical, Hyperion DeFi, Basel Medical, TAO Synergies, Iterum Therapeutics, Intensity Therapeutics, and IBio Common. P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior ca... More
P3 Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure P3 Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess P3 Health Partners upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 37.35 | |||
| Value At Risk | (12.38) | |||
| Potential Upside | 11.14 |
P3 Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for P3 Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as P3 Health's standard deviation. In reality, there are many statistical measures that can use P3 Health historical prices to predict the future P3 Health's volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (1.63) | |||
| Total Risk Alpha | (2.37) | |||
| Treynor Ratio | (1.43) |
P3 Health February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.15) | |||
| Market Risk Adjusted Performance | (1.42) | |||
| Mean Deviation | 4.78 | |||
| Coefficient Of Variation | (493.10) | |||
| Standard Deviation | 7.53 | |||
| Variance | 56.74 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | (1.63) | |||
| Total Risk Alpha | (2.37) | |||
| Treynor Ratio | (1.43) | |||
| Maximum Drawdown | 37.35 | |||
| Value At Risk | (12.38) | |||
| Potential Upside | 11.14 | |||
| Skewness | 1.6 | |||
| Kurtosis | 6.8 |
P3 Health Partners Backtested Returns
P3 Health Partners retains Efficiency (Sharpe Ratio) of -0.19, which implies the company had a -0.19 % return per unit of price deviation over the last 3 months. P3 Health exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check P3 Health's information ratio of (0.22), and Market Risk Adjusted Performance of (1.42) to confirm the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 1.07, which implies a somewhat significant risk relative to the market. P3 Health returns are very sensitive to returns on the market. As the market goes up or down, P3 Health is expected to follow. At this point, P3 Health Partners has a negative expected return of -1.51%. Please make sure to check P3 Health's treynor ratio, and the relationship between the standard deviation and kurtosis , to decide if P3 Health Partners performance from the past will be repeated sooner or later.
Auto-correlation | 0.80 |
Very good predictability
P3 Health Partners has very good predictability. Overlapping area represents the amount of predictability between P3 Health time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of P3 Health Partners price movement. The serial correlation of 0.8 indicates that around 80.0% of current P3 Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.8 | |
| Spearman Rank Test | 0.92 | |
| Residual Average | 0.0 | |
| Price Variance | 0.4 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, P3 Health Partners reported net income of (310.38 Million). This is 190.94% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 154.36% higher than that of the company.
PIII Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses P3 Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of P3 Health could also be used in its relative valuation, which is a method of valuing P3 Health by comparing valuation metrics of similar companies.P3 Health is currently under evaluation in net income category among its peers.
P3 Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, P3 Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to P3 Health's managers, analysts, and investors.Environmental | Governance | Social |
P3 Health Institutional Holders
Institutional Holdings refers to the ownership stake in P3 Health that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of P3 Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing P3 Health's value.| Shares | Bank Of America Corp | 2025-06-30 | 16.0 | Royal Bank Of Canada | 2025-06-30 | 2.0 | Fmr Inc | 2025-06-30 | 2.0 | Jane Street Group Llc | 2025-03-31 | 0.0 | Warberg Asset Management Llc | 2025-03-31 | 0.0 | Hightower Advisors, Llc | 2025-03-31 | 0.0 | Smh Capital Inc. | 2025-06-30 | 0.0 | Citigroup Inc | 2025-03-31 | 0.0 | Wealthedge Investment Advisors, Llc | 2025-03-31 | 0.0 | Alyeska Investment Group, L.p. | 2025-06-30 | 180.9 K | Vanguard Group Inc | 2025-06-30 | 38.4 K |
PIII Fundamentals
| Return On Equity | -2.03 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.13) % | ||||
| Current Valuation | 234.31 M | ||||
| Shares Outstanding | 3.27 M | ||||
| Shares Owned By Insiders | 62.08 % | ||||
| Shares Owned By Institutions | 10.97 % | ||||
| Number Of Shares Shorted | 15.84 K | ||||
| Price To Book | 0.62 X | ||||
| Price To Sales | 0.30 X | ||||
| Revenue | 1.5 B | ||||
| Gross Profit | (58.45 M) | ||||
| EBITDA | (197.76 M) | ||||
| Net Income | (310.38 M) | ||||
| Cash And Equivalents | 63.15 M | ||||
| Cash Per Share | 1.52 X | ||||
| Total Debt | 166.16 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 0.75 X | ||||
| Book Value Per Share | (5.72) X | ||||
| Cash Flow From Operations | (110.13 M) | ||||
| Short Ratio | 1.09 X | ||||
| Earnings Per Share | (57.16) X | ||||
| Target Price | 10.25 | ||||
| Number Of Employees | 360 | ||||
| Beta | 0.88 | ||||
| Market Capitalization | 436.76 M | ||||
| Total Asset | 783.42 M | ||||
| Retained Earnings | (503.19 M) | ||||
| Working Capital | (312.27 M) | ||||
| Net Asset | 783.42 M |
About P3 Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze P3 Health Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of P3 Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of P3 Health Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is there potential for Health Care Equipment & Supplies market expansion? Will PIII introduce new products? Factors like these will boost the valuation of P3 Health. Anticipated expansion of PIII directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (57.16) | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets | Return On Equity |
P3 Health Partners's market price often diverges from its book value, the accounting figure shown on PIII's balance sheet. Smart investors calculate P3 Health's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since P3 Health's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between P3 Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding P3 Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.